Epigenomics AG EPGNF:OTCQX

RT Quote | Exchange | USD
Last | 05/17/22 EDT
0.5469UNCH (UNCH)
52 week range
0.51 - 1.92
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5469
  • 52 Week High1.92
  • 52 Week High Date06/11/21
  • 52 Week Low0.51
  • 52 Week Low Date01/21/22

Key Stats

  • Market Cap8.22M
  • Shares Out15.98M
  • 10 Day Average Volume500
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.17

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5469
  • 52 Week High1.92
  • 52 Week High Date06/11/21
  • 52 Week Low0.51
  • 52 Week Low Date01/21/22
  • Market Cap8.22M
  • Shares Out15.98M
  • 10 Day Average Volume500
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.17

RATIOS/PROFITABILITY

  • EPS (TTM)-0.33
  • P/E (TTM)-1.65
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Epigenomics AG

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product...
Gregory Hamilton
Chief Executive Officer
Address
Geneststrasse 5
Berlin
10829
Germany